Ceisteanna ó Cheannairí - Leaders' Questions
Dail Éireann — 2023-05-18
============================================================

Micheál Martin (FF), Cork South-Central

In respect of treatment, the Government has substantially increased funding for new innovative medicines for rare diseases, investing €100 million over the last three budgets. More than 100 new medicines have been approved, including 39 orphan medicines to treat rare diseases. We also committed €2.7 million to support the implementation of the national strategy for accelerating genetics and genomic medicine in Ireland. As I stated earlier, we progressed Irish entry into the Horizon Europe partnerships on rare diseases and personalised medicine. As I said, both those tracks - research and participation in the networks - are key, as is the implementation of the strategy on accelerating genetics and genomic medicine. A new national office of genetics and genomics and the appointment of key staff will all be provided for with a national director for genetics and genomics, a bioinformatics laboratory, a director, two clinical genetic consultants and six genetic counsellors. That has been welcomed by the rare disease community in Ireland and will be of benefit to many people living with a rare disease but I take the point that the networks need to be resourced as well.

---

Source: Houses of the Oireachtas. Licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). The Official Report is revised after first publication; the fetch timestamp below identifies the version quoted.

Record URI: https://data.oireachtas.ie/akn/ie/debateRecord/dail/2023-05-18/debate/main
Retrieved: 2026-08-14T04:51:55+00:00
Sitting date: 2023-05-18